EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy

Juhee Lee, Han Sang Lee, Kon Chu iD

encephalitis · 2022

DOI: 10.47936/encephalitis.2021.00143 ↗

Kurz gefasst

Fallbericht in der Zeitschrift encephalitis, 2022. Verfasst von Juhee Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal gammopathy of undetermined significance (MGUS) is associated with several autoimmune conditions, including central nervous system (CNS) vasculitis. Epstein-Barr virus (EBV) is a pathogen capable of triggering a systemic immune response and is involved in the occurrence of a wide range of B-cell lymphoproliferative disorders. In systemic autoimmune diseases, EBV infection is suspected to play a central role in pathogenesis. Here, we present a case that was thought to be a systemic autoimmune disease and CNS vasculitis that developed after EBV infection, demonstrating that rituximab is effective for the treatment.

Schlagwörter

Stichwörter der Autor:innen

Central nervous system vasculitisEpstein-Barr virusMonoclonal gammopathy of undetermined significanceRituximab

Autor:innen und Institutionen

  • Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Center for Hospital Medicine, Seoul National University Hospital, Seoul, Korea.
  • Comprehensive Epilepsy Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Kon Chu

Zitieren

APA

Lee, J., Lee, H. S., & Chu, K. (2022). Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. encephalitis. https://doi.org/10.47936/encephalitis.2021.00143

Vancouver

Lee J, Lee HS, Chu K. Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. encephalitis. 2022. doi:10.47936/encephalitis.2021.00143

BibTeX
@article{Lee2022,
  author = {Lee, Juhee and Lee, Han Sang and Chu, Kon},
  title = {Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy},
  journal = {encephalitis},
  year = {2022},
  doi = {10.47936/encephalitis.2021.00143}
}
Kostenlos starten →